Five Additions and Five Deletions in Poliwogg Healthcare Innovation Index Quarterly Reconstitution
New York, NY, Friday, March 9, 2018 — The Poliwogg Healthcare Innovation IndexSM (TICKER: PHIX) will add five constituents and drop five constituents in its quarterly reconstitution, effective 6:00 PM (EST) Sunday, March 18, 2018, maintaining the number of index components at 30.
The deletions from PHIX are: Bluebird Bio Inc (TICKER: BLUE US), Immunomedics Inc (TICKER: IMMU US), Loxo Oncology Inc (TICKER: LOXO US), Agios Pharmaceuticals Inc (TICKER: AGIO US), Nektar Therapeutics (TICKER: NKTR US).
A complete list of constituents and weights will be posted on the Poliwogg Medical IndexesSM website (www.poliwoggindexes.com), as of the effective date.
The Poliwogg Healthcare Innovation Index (TICKER: PHIX) is designed to capture merger and acquisition opportunities in the pharmaceutical industry. PHIX consists of companies included in the Poliwogg Biopharma Merger & Acquisition Index (PBMA) that pass additional screens.
Detailed information on the Poliwogg Healthcare Innovation IndexSM including constituent data, rules and price information is available at www.poliwoggindexes.com. Data is also available through most vendors of financial data.
S-Network Global Indexes, Inc. is a publisher and developer of proprietary and custom indexes. Founded in 1997, S-Network publishes over 200 indexes, which serve as the underlying portfolios for financial products with over USD 8 billion in assets under management. S-Network indexes, which are supported by a state-of-the-art technology platform, are known for their transparency and efficiency. More...
11 Additions and 11 Deletions in Poliwogg Healthcare Innovation Index Quarterly Reconstitution
Jun 8, 2018
31 Additions and Three Deletions in Poliwogg Biopharma Merger & Acquisition Index Semi-Annual Reconstitution
Jun 8, 2018
40 Additions and 22 Deletions in Poliwogg Medical Breakthroughs Index Semi-Annual Reconstitution
Jun 7, 2018
S-Network Global Indexes, Inc.
267 Fifth Avenue, Suite 508
Phone: (646) 467-7928